Hsu Chih-Yi, Tsai Yi-Hsuan, Lin Chiung-Yu, Chang Ya-Chun, Chen Hung-Cheng, Chang Yu-Ping, Chen Yu-Mu, Huang Kuo-Tung, Wang Yi-Hsi, Wang Chin-Chou, Lin Meng-Chih, Fang Wen-Feng
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
J Pers Med. 2021 Sep 13;11(9):910. doi: 10.3390/jpm11090910.
We investigated the best timing for using the National Early Warning Score 2 (NEWS2) for predicting sepsis outcomes and whether combining the NEWS2 and the Sequential Organ Failure Assessment (SOFA) was applicable for mortality risk stratification in intensive care unit (ICU) patients with severe sepsis. All adult patients who met the Third International Consensus Definitions for Sepsis and Septic Shock criteria between August 2013 and January 2017 with complete clinical parameters and laboratory data were enrolled as a derivation cohort. The primary outcomes were the 7-, 14-, 21-, and 28-day mortalities. Furthermore, another group of patients under the same setting between January 2020 and March 2020 were also enrolled as a validation cohort. In the derivation cohort, we included 699 consecutive adult patients. The 72 h NEWS2 had good discrimination for predicting 7-, 14-, 21-, and 28-day mortalities (AUC: 0.780, 0.724, 0.700, and 0.667, respectively) and was not inferior to the SOFA (AUC: 0.740, 0.680, 0.684, and 0.677, respectively). With the new combined NESO tool, the hazard ratio was 1.854 (1.203-2.950) for the intermediate-risk group and 6.810 (3.927-11.811) for the high-risk group relative to the low-risk group. This finding was confirmed in the validation cohort using a separated survival curve for 28-day mortality. The 72 h NEWS2 alone was non-inferior to the admission SOFA or day 3 SOFA for predicting sepsis outcomes. The NESO tool was found to be useful for 7-, 14-, 21-, and 28-day mortality risk stratification in patients with severe sepsis.
我们研究了使用国家早期预警评分2(NEWS2)预测脓毒症预后的最佳时机,以及将NEWS2与序贯器官衰竭评估(SOFA)相结合是否适用于重症监护病房(ICU)严重脓毒症患者的死亡风险分层。2013年8月至2017年1月期间,所有符合脓毒症和脓毒性休克的第三次国际共识定义标准且临床参数和实验室数据完整的成年患者被纳入一个推导队列。主要结局为7天、14天、21天和28天死亡率。此外,2020年1月至2020年3月期间处于相同环境的另一组患者也被纳入一个验证队列。在推导队列中,我们纳入了699例连续的成年患者。72小时NEWS2在预测7天、14天、21天和28天死亡率方面具有良好的辨别力(AUC分别为0.780、0.724、0.700和0.667),且不劣于SOFA(AUC分别为0.740、0.680、0.684和0.677)。对于新的组合NESO工具,中风险组相对于低风险组的风险比为1.854(1.203 - 2.950),高风险组为6.810(3.927 - 11.811)。这一发现通过验证队列中28天死亡率的单独生存曲线得到了证实。单独使用72小时NEWS2在预测脓毒症预后方面不劣于入院时的SOFA或第3天的SOFA。NESO工具被发现可用于严重脓毒症患者7天、14天、21天和28天死亡风险分层。